BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Müller HL. Craniopharyngioma. Endocr Rev 2014;35:513-43. [PMID: 24467716 DOI: 10.1210/er.2013-1115] [Cited by in Crossref: 187] [Cited by in F6Publishing: 141] [Article Influence: 23.4] [Reference Citation Analysis]
Number Citing Articles
1 Nuijts MA, Veldhuis N, Stegeman I, van Santen HM, Porro GL, Imhof SM, Schouten-van Meeteren AYN. Visual functions in children with craniopharyngioma at diagnosis: A systematic review. PLoS One 2020;15:e0240016. [PMID: 33002047 DOI: 10.1371/journal.pone.0240016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Nie C, Ye Y, Wu J, Zhao H, Jiang X, Wang H. Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience. Front Oncol 2022;12:755342. [PMID: 35223463 DOI: 10.3389/fonc.2022.755342] [Reference Citation Analysis]
3 Jung SY, Lee YJ, Lee HJ, Lee YA, Moon JS, Ko JS, Yang SW, Shin CH. Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma. Ann Pediatr Endocrinol Metab 2017;22:189-96. [PMID: 29025206 DOI: 10.6065/apem.2017.22.3.189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Di Iorgi N, Morana G, Allegri AE, Napoli F, Gastaldi R, Calcagno A, Patti G, Loche S, Maghnie M. Classical and non-classical causes of GH deficiency in the paediatric age. Best Pract Res Clin Endocrinol Metab 2016;30:705-36. [PMID: 27974186 DOI: 10.1016/j.beem.2016.11.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
5 Müller HL, Reichel J, Boekhoff S, Warmuth-Metz M, Eveslage M, Peng J, Flitsch J. Low concordance between surgical and radiological assessment of degree of resection and treatment-related hypothalamic damage: results of KRANIOPHARYNGEOM 2007. Pituitary 2018;21:371-8. [PMID: 29589225 DOI: 10.1007/s11102-018-0883-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Hussein Z, Glynn N, Martin N, Alkrekshi A, Mendoza N, Nair R, McCullough K, Marcus HJ, Dorward N, Grieve J, Fersht N, Dyson E, Bouloux PM, Druce M, Baldeweg SE. Temporal trends in craniopharyngioma management and long-term endocrine outcomes: A multicentre cross-sectional study. Clin Endocrinol (Oxf) 2021;94:242-9. [PMID: 32949016 DOI: 10.1111/cen.14334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Gandhi H, Sharma AK, Mahant S, Kapoor DN. Recent advancements in brain tumor targeting using magnetic nanoparticles. Ther Deliv 2020;11:97-112. [PMID: 31914859 DOI: 10.4155/tde-2019-0077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Chemaitilly W, Armstrong GT, Gajjar A, Hudson MM. Hypothalamic-Pituitary Axis Dysfunction in Survivors of Childhood CNS Tumors: Importance of Systematic Follow-Up and Early Endocrine Consultation. JCO 2016;34:4315-9. [DOI: 10.1200/jco.2016.70.1847] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Daubenbüchel AM, Müller HL. Neuroendocrine Disorders in Pediatric Craniopharyngioma Patients. J Clin Med 2015;4:389-413. [PMID: 26239246 DOI: 10.3390/jcm4030389] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
10 Amayiri N, Spitaels A, Zaghloul M, Figaji A, Cavalheiro S, Muller HL, Elhassan M, Parkes J, Mushtaq N, Beltagy ME, Yousef YA, Esiashvili N, Sullivan M, da Costa MD, Dastoli P, Mubarak F, Bartels U, Chamdine O, Davidson A, Musharbash A, Alcasabas P, Bouffet E, Bailey S. SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settings. Pediatr Blood Cancer 2020;:e28493. [PMID: 32790146 DOI: 10.1002/pbc.28493] [Reference Citation Analysis]
11 Park Y, Ohn K, Ahn YJ, Jang J, Park SH. Compressive Optic Neuropathy with a Concurrent Mutation of Leber's Hereditary Optic Neuropathy: A Case Report. Neuroophthalmology 2020;44:387-90. [PMID: 33335345 DOI: 10.1080/01658107.2019.1703197] [Reference Citation Analysis]
12 van Roessel IMAA, van Schaik J, Meeteren AYNS, Boot AM, der Grinten HLC, Clement SC, van Iersel L, Han KS, van Trotsenburg ASP, Vandertop WP, Kremer LCM, van Santen HM. Body mass index at diagnosis of a childhood brain tumor; a reflection of hypothalamic-pituitary dysfunction or lifestyle? Support Care Cancer 2022. [PMID: 35416504 DOI: 10.1007/s00520-022-07031-4] [Reference Citation Analysis]
13 Schelini JC, Cavalheiro S, Dastoli PA, Hirai ÉR, Atallah C, Costa M, Nicacio J, Capellano AM, Silva N, Zymberg S, de Paula Santos R. Endoscopic endonasal transsphenoidal approach for pediatric craniopharyngiomas: A case series. Int J Pediatr Otorhinolaryngol 2020;130:109786. [PMID: 31812002 DOI: 10.1016/j.ijporl.2019.109786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zou Y, Meng L, Wang Q, He Z, Hu C, Shan M, Wang D, Yu X. Identification and Functional Enrichment Analysis of Potential Diagnostic and Therapeutic Targets in Adamantinomatous Craniopharyngioma. Journal of Computational Biology 2020;27:55-68. [DOI: 10.1089/cmb.2019.0184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang J, He M, Liu Z, Song Y, Wang Y, Liang R, Chen H, Xu J. Impact of neutrophil-lymphocyte ratio on long-term outcome in patients with craniopharyngioma. Medicine (Baltimore) 2018;97:e12375. [PMID: 30213000 DOI: 10.1097/MD.0000000000012375] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Emet DC, Ozon A, Alikasifoglu A, Kandemir N, Gonc N. Alpha-Melanocyte-Stimulating Hormone is Elevated in Hypothalamic Obesity Associated with Childhood Craniopharyngioma. Obesity (Silver Spring) 2021;29:402-8. [PMID: 33491320 DOI: 10.1002/oby.23087] [Reference Citation Analysis]
17 Chemaitilly W, Cohen LE. DIAGNOSIS OF ENDOCRINE DISEASE: Endocrine late-effects of childhood cancer and its treatments. Eur J Endocrinol 2017;176:R183-203. [PMID: 28153840 DOI: 10.1530/EJE-17-0054] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 8.6] [Reference Citation Analysis]
18 Shi X, Zhou Z, Wu B, Zhang Y, Qian H, Sun Y, Yang Y, Yu Z, Tang Z, Lu S. Outcome of Radical Surgical Resection for Craniopharyngioma with Hypothalamic Preservation: A Single-Center Retrospective Study of 1054 Patients. World Neurosurg 2017;102:167-80. [PMID: 28254603 DOI: 10.1016/j.wneu.2017.02.095] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
19 Foschi M, Sambati L, Zoli M, Pierangeli G, Cecere A, Mignani F, Barletta G, Sturiale C, Faustini-Fustini M, Milanese L, Cortelli P, Mazzatenta D, Provini F. Site and type of craniopharyngiomas impact differently on 24-hour circadian rhythms and surgical outcome. A neurophysiological evaluation. Auton Neurosci 2017;208:126-30. [PMID: 28843459 DOI: 10.1016/j.autneu.2017.08.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
20 Martinez-barbera JP. 60 YEARS OF NEUROENDOCRINOLOGY: Biology of human craniopharyngioma: lessons from mouse models. Journal of Endocrinology 2015;226:T161-72. [DOI: 10.1530/joe-15-0145] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
21 Hage M, Lombès M, Chanson P. Craniopharyngiomes : progrès en pathogénie et thérapeutique. Annales d'Endocrinologie 2014;75:S46-54. [DOI: 10.1016/s0003-4266(14)70026-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 McCrea HJ, George E, Settler A, Schwartz TH, Greenfield JP. Pediatric Suprasellar Tumors. J Child Neurol 2016;31:1367-76. [PMID: 26676303 DOI: 10.1177/0883073815620671] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
23 Goschzik T, Gessi M, Dreschmann V, Gebhardt U, Wang L, Yamaguchi S, Wheeler DA, Lauriola L, Lau CC, Müller HL, Pietsch T. Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma. J Neuropathol Exp Neurol 2017;76:126-34. [PMID: 28069929 DOI: 10.1093/jnen/nlw116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
24 van Roessel IMAA, Schouten-van Meeteren AYN, Meijer L, Hoving EW, Bakker B, van Santen HM. Transition From Diencephalic Syndrome to Hypothalamic Obesity in Children With Suprasellar Low Grade Glioma: A Case Series. Front Endocrinol 2022;13:846124. [DOI: 10.3389/fendo.2022.846124] [Reference Citation Analysis]
25 Müller HL. Risk-adapted, long-term management in childhood-onset craniopharyngioma. Pituitary 2017;20:267-81. [DOI: 10.1007/s11102-016-0751-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
26 Briggs RG, Ahsan SA, Conner AK, Nix CE, Jacobs CC, Jones RG, Sheets JR, Palejwala AH, Chendeb K, Sughrue ME. Neurochemical supplementation in patients with depressed levels of participation after brain tumor surgery: Rationale and preliminary results. J Clin Neurosci 2020;71:93-6. [PMID: 31771803 DOI: 10.1016/j.jocn.2019.10.004] [Reference Citation Analysis]
27 Hoffmann A, Boekhoff S, Gebhardt U, Sterkenburg AS, Daubenbüchel AM, Eveslage M, Müller HL. History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis. Eur J Endocrinol 2015;173:853-62. [PMID: 26392473 DOI: 10.1530/EJE-15-0709] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 4.4] [Reference Citation Analysis]
28 Gauden AJ, Harley B, Pears C, Wickremesekera A, Parker A, Robinson S, Baguley C, Wormald PJ. A regional Australasian experience of extended endoscopic transsphenoidal surgery for craniopharyngioma: Progression of the mentoring model. J Clin Neurosci 2019;68:188-93. [PMID: 31303398 DOI: 10.1016/j.jocn.2019.06.032] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Pal R, Dutta P, Chatterjee D, Ahuja C, Singh A. Pendular See-Saw Nystagmus: A Rare Presenting Manifestation of Craniopharyngioma. Neuroophthalmology 2020;45:126-9. [PMID: 34103775 DOI: 10.1080/01658107.2019.1693602] [Reference Citation Analysis]
30 Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AM, Müller HL. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 2015;17:1029-38. [PMID: 25838139 DOI: 10.1093/neuonc/nov044] [Cited by in Crossref: 98] [Cited by in F6Publishing: 80] [Article Influence: 14.0] [Reference Citation Analysis]
31 Witchel SF, Plant TM. Neurobiology of puberty and its disorders. Handb Clin Neurol 2021;181:463-96. [PMID: 34238478 DOI: 10.1016/B978-0-12-820683-6.00033-6] [Reference Citation Analysis]
32 Heinks K, De Schutter-Nüsse C, Boekhoff S, Bogusz A, Zhu J, Peng J, Müller HL. Periostin concentrations in childhood-onset craniopharyngioma patients. J Endocrinol Invest 2019;42:815-24. [PMID: 30474798 DOI: 10.1007/s40618-018-0987-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
33 Hoffmann A, Bootsveld K, Gebhardt U, Daubenbüchel AM, Sterkenburg AS, Müller HL. Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. Eur J Endocrinol 2015;173:389-97. [PMID: 26088821 DOI: 10.1530/EJE-15-0422] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 4.6] [Reference Citation Analysis]
34 Sterkenburg AS, Hoffmann A, Reichel J, Lohle K, Eveslage M, Warmuth-Metz M, Müller HL. Nuchal Skinfold Thickness: A Novel Parameter for Assessment of Body Composition in Childhood Craniopharyngioma. J Clin Endocrinol Metab 2016;101:4922-30. [PMID: 27680877 DOI: 10.1210/jc.2016-2547] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Bogusz A, Müller HL. Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up. Expert Review of Neurotherapeutics 2018;18:793-806. [DOI: 10.1080/14737175.2018.1528874] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
36 Prieto R, Rosdolsky M, Hofecker V, Barrios L, Pascual JM. Craniopharyngioma treatment: an updated summary of important clinicopathological concepts. Expert Rev Endocrinol Metab 2020;15:261-82. [PMID: 32615875 DOI: 10.1080/17446651.2020.1770081] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
37 Kaltsas GA, Kolomodi D, Randeva H, Grossman A. Nonneuroendocrine Neoplasms of the Pituitary Region. J Clin Endocrinol Metab 2019;104:3108-23. [PMID: 30779850 DOI: 10.1210/jc.2018-01871] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Müller HL. Management of Hypothalamic Obesity. Endocrinol Metab Clin North Am 2020;49:533-52. [PMID: 32741487 DOI: 10.1016/j.ecl.2020.05.009] [Reference Citation Analysis]
39 Sousa Santos F, Nunes Dias L, Henriques V, Canas Marques C, Chorão M, Sequeira Duarte J, Limbert C, Costa J, Graça J, Vasconcelos C, Cabral J, Ramos S. Non-adenomatous sellar lesions: single-centre 10-year experience. Hormones 2018;17:557-63. [DOI: 10.1007/s42000-018-0064-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Jastania RA, Saeed M, Al-Khalidi H, AlQuthami K, Nageeti TH, Al-Allaf FA, Valerie K, Taher MM. Adamantinomatous Craniopharyngioma in an Adult: A Case Report with NGS Analysis. Int Med Case Rep J 2020;13:123-37. [PMID: 32368160 DOI: 10.2147/IMCRJ.S243405] [Reference Citation Analysis]
41 Bresson D, Herman P, Polivka M, Froelich S. Sellar Lesions/Pathology. Otolaryngol Clin North Am 2016;49:63-93. [PMID: 26614829 DOI: 10.1016/j.otc.2015.09.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
42 Massa D, Glerean M, Rasmussen J, Altszul M, Fainstein-Day P, Ajler P. Craniopharyngiomas: experience and results. Neurocirugia (Astur : Engl Ed) 2021;32:105-13. [PMID: 32446620 DOI: 10.1016/j.neucir.2020.03.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Emmert AS, Hussein AE, Slobodian O, Krueger B, Bhabhra R, Hagen MC, Pickle S, Forbes JA. Case Report of Transgender Patient with Gonadotropic Dysfunction Secondary to Craniopharyngioma: Toward Improving Understanding of Biopsychosocial Dynamics of Gender Identity in Neurosurgical Care. World Neurosurg 2021;145:448-53. [PMID: 33045454 DOI: 10.1016/j.wneu.2020.09.168] [Reference Citation Analysis]
44 Kothari V, Cardona Z, Eisenberg Y. Adipsic diabetes insipidus. Handb Clin Neurol 2021;181:261-73. [PMID: 34238462 DOI: 10.1016/B978-0-12-820683-6.00019-1] [Reference Citation Analysis]
45 Whelan R, Hengartner A, Folzenlogen Z, Prince E, Hankinson TC. Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review. Childs Nerv Syst 2020;36:1635-42. [DOI: 10.1007/s00381-020-04677-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Westcott GP, Mulla CM, Hennessey JV. USE OF THE FREE THYROXINE INDEX TO REFINE THE LOWER LIMIT OF A FREE THYROXINE IMMUNOASSAY FOR DETECTION OF SECONDARY HYPOTHYROIDISM. Endocr Pract 2021;27:8-14. [PMID: 33475506 DOI: 10.4158/EP-2020-0210] [Reference Citation Analysis]
47 Di Somma C, Scarano E, Barrea L, Solari D, Riccio E, Arianna R, Cavallo LM, Romano F, Di Benedetto E, Rodriguez A, de Alteriis G, Colao A. Craniopharyngioma, Chronotypes and Metabolic Risk Profile. Nutrients 2021;13:3444. [PMID: 34684445 DOI: 10.3390/nu13103444] [Reference Citation Analysis]
48 Ni W, Shi X. Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review. World Neurosurg 2018;118:e59-71. [PMID: 29945001 DOI: 10.1016/j.wneu.2018.06.121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Pena AH, Chaudhry A, Seidman RJ, Peyster R, Bangiyev L. Ectopic craniopharyngioma of the fourth ventricle in a patient with Gardner syndrome. Clin Imaging 2016;40:232-6. [PMID: 26995577 DOI: 10.1016/j.clinimag.2015.11.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
50 Paschou SA, Vryonidou A, Goulis DG. Pituitary incidentalomas: A guide to assessment, treatment and follow-up. Maturitas 2016;92:143-9. [PMID: 27621252 DOI: 10.1016/j.maturitas.2016.08.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
51 Chen Z, Ma Z, He W, Shou X, Ye Z, Zhang Y, Zhang Q, Qiao N, Zhou X, Cao X, He M, Zhang Z, Ye H, Li Y, Li S, Zhao Y, Shen M, Wang Y. Impact of Pituitary Stalk Preservation on Tumor Recurrence/Progression and Surgically Induced Endocrinopathy After Endoscopic Endonasal Resection of Suprasellar Craniopharyngiomas. Front Neurol 2021;12:753944. [PMID: 34803890 DOI: 10.3389/fneur.2021.753944] [Reference Citation Analysis]
52 Romigi A, Feola T, Cappellano S, De Angelis M, Pio G, Caccamo M, Testa F, Vitrani G, Centonze D, Colonnese C, Esposito V, Jaffrain-rea M. Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update. Front Neurol 2022;12:817257. [DOI: 10.3389/fneur.2021.817257] [Reference Citation Analysis]
53 Wai Wye NH, Naffi AA, Othman O, Bastion MC. A Rare Occurrence of Craniopharyngioma Causing Visual Disturbance in Pregnancy. Cureus 2021;13:e18700. [PMID: 34790457 DOI: 10.7759/cureus.18700] [Reference Citation Analysis]
54 Meijneke RW, Schouten-van Meeteren AY, de Boer NY, van Zundert S, van Trotsenburg PA, Stoelinga F, van Santen HM. Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment. J Pediatr Endocrinol Metab 2015;28:59-63. [PMID: 25381948 DOI: 10.1515/jpem-2014-0338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
55 Chen M, Zheng SH, Liu Y, Shi J, Qi ST. Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma. J Neurol Sci 2016;360:49-54. [PMID: 26723972 DOI: 10.1016/j.jns.2015.11.042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
56 Steiert C, Grauvogel J, Roelz R, Demerath T, Schnell D, Beck J, Coenen VA, Reinacher PC. Stereotactic cysto-ventricular catheters in craniopharyngiomas: an effective minimally invasive method to improve visual impairment and achieve long-term cyst volume reduction. Neurosurg Rev 2021. [PMID: 33674982 DOI: 10.1007/s10143-021-01510-8] [Reference Citation Analysis]
57 La Corte E, Younus I, Pivari F, Selimi A, Ottenhausen M, Forbes JA, Pisapia DJ, Dobri GA, Anand VK, Schwartz TH. BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series. Pituitary 2018;21:571-83. [DOI: 10.1007/s11102-018-0909-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
58 Hong AR, Lee M, Lee JH, Kim JH, Kim YH, Choi HJ. Clinical Implication of Individually Tailored Segmentation Method for Distorted Hypothalamus in Craniopharyngioma. Front Endocrinol (Lausanne) 2021;12:763523. [PMID: 34987474 DOI: 10.3389/fendo.2021.763523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Jokonya L, Reid T, Kasambala M, Mduluza-Jokonya TL, Fieggen G, Mduluza T, Kalangu KKN, Naicker T. Antimicrobial effects of craniopharyngioma cystic fluid. Childs Nerv Syst 2020;36:2641-6. [PMID: 32700040 DOI: 10.1007/s00381-020-04825-x] [Reference Citation Analysis]
60 Van Schaik J, Burghard M, Lequin MH, van Maren EA, van Dijk AM, Takken T, Rehorst-Kleinlugtenbelt LB, Bakker B, Meijer L, Hoving EW, Fiocco M, Schouten-van Meeteren AYN, Tissing WJE, van Santen HM. Resting energy expenditure in children at risk of hypothalamic dysfunction. Endocr Connect 2022;11:e220276. [PMID: 35904233 DOI: 10.1530/EC-22-0276] [Reference Citation Analysis]
61 Lubuulwa J, Lei T. Pathological and Topographical Classification of Craniopharyngiomas: A Literature Review. J Neurol Surg Rep 2016;77:e121-7. [PMID: 27556005 DOI: 10.1055/s-0036-1588060] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
62 Pikis S, Mantziaris G, Lavezzo K, Dabhi N, Sheehan J. Stereotactic radiosurgery for craniopharyngiomas. Acta Neurochir (Wien) 2021;163:3201-7. [PMID: 34518903 DOI: 10.1007/s00701-021-04990-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 Witchel SF, Topaloglu AK. Puberty. Yen and Jaffe's Reproductive Endocrinology. Elsevier; 2019. pp. 394-446.e16. [DOI: 10.1016/b978-0-323-47912-7.00017-2] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
64 Roth CL, D'Ambrosio G, Elfers C. Activation of nuclear factor kappa B pathway and reduction of hypothalamic oxytocin following hypothalamic lesions. J Syst Integr Neurosci 2016;2:79-84. [PMID: 27512604 DOI: 10.15761/JSIN.1000114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Wang F, He Y, Li C, Wang Y, Zhong L. Malignant Craniopharyngioma: A Report of Seven Cases and Review of the Literature. World Neurosurgery 2020;135:e194-201. [DOI: 10.1016/j.wneu.2019.11.111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Gebert D, Auer MK, Stieg MR, Freitag MT, Lahne M, Fuss J, Schilbach K, Schopohl J, Stalla GK, Kopczak A. De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function. Psychoneuroendocrinology 2018;88:61-9. [PMID: 29175721 DOI: 10.1016/j.psyneuen.2017.11.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
67 Kang J, Cao L, Yuan T, Jin L, Shi Y, Ma G, Qiao N, Li C, Zhang Y, Zuo Z, Gui S. Predicting the location of the preoptic and anterior hypothalamic region by visualizing the thermoregulatory center on fMRI in craniopharyngioma using cold and warm stimuli. Aging (Albany NY) 2021;13:10087-98. [PMID: 33818420 DOI: 10.18632/aging.202766] [Reference Citation Analysis]
68 Wang G, Zhang X, Feng M, Guo F. Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngioma: a meta-analysis. J Surg Res 2018;226:131-9. [PMID: 29661278 DOI: 10.1016/j.jss.2018.01.029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
69 Dietz N, Sharma M, John K, Wang D, Ugiliweneza B, Mokshagundam S, Bjurström MF, Boakye M, Williams BJ, Andaluz N. 90-Day Bundled Payment Simulation, Health Care Utilization, and Complications following Craniopharyngioma Resection in Adult Patients. J Neurol Surg B Skull Base. [DOI: 10.1055/s-0041-1740395] [Reference Citation Analysis]
70 Martínez-Ortega A, Flores-Martinez Á, Venegas-Moreno E, Dios E, Del Can D, Rivas E, Kaen A, Cárdenas Ruiz-Valdepeñas E, Fajardo E, Roldán F, González-Rivera N, Oliva R, Fernández-Peña JI, Soto-Moreno A, Cano DA. Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics. J Clin Med 2022;11:281. [PMID: 35012020 DOI: 10.3390/jcm11010281] [Reference Citation Analysis]
71 Qin C, Hu W, Wang X, Ma X. Application of Artificial Intelligence in Diagnosis of Craniopharyngioma. Front Neurol 2021;12:752119. [PMID: 35069406 DOI: 10.3389/fneur.2021.752119] [Reference Citation Analysis]
72 Korula S, Beryl S, Kamath V, Mathew SS, Joseph V. Turner Syndrome and Craniopharyngioma. Indian J Pediatr 2021. [PMID: 34843061 DOI: 10.1007/s12098-021-03990-4] [Reference Citation Analysis]
73 Erfurth EM. Obesity and Metabolic Disturbances in Adamantinomatous Craniopharyngioma Patients. In: Martinez-barbera JP, Lilian Andoniadou C, editors. Basic Research and Clinical Aspects of Adamantinomatous Craniopharyngioma. Cham: Springer International Publishing; 2017. pp. 85-99. [DOI: 10.1007/978-3-319-51890-9_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
74 Thimsen V, Hölsken A, Buchfelder M, Flitsch J, Fahlbusch R, Stefanits H, Losa M, Jones DT, Buslei R. EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts. Sci Rep 2016;6:29731. [PMID: 27431859 DOI: 10.1038/srep29731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
75 Hoffmann A, Özyurt J, Lohle K, Reichel J, Thiel CM, Müller HL. First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma. Endocrine 2017;56:175-85. [PMID: 28213803 DOI: 10.1007/s12020-017-1257-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
76 Kopparapu S, Khalafallah AM, Botros D, Carey AR, Rodriguez FJ, Duan D, Rowan NR, Mukherjee D. Predictors of Postoperative Visual Outcome After Surgical Intervention for Craniopharyngiomas. World Neurosurg 2021;148:e589-99. [PMID: 33482413 DOI: 10.1016/j.wneu.2021.01.044] [Reference Citation Analysis]
77 Huang CC, Lin KL, Wu CT, Jung SM, Wang CJ, Chen YC, Lo FS. Clinical and endocrinological manifestations of childhood-onset craniopharyngioma before surgical removal: A report from one medical center in Taiwan. Pediatr Neonatol 2021;62:181-6. [PMID: 33376065 DOI: 10.1016/j.pedneo.2020.08.014] [Reference Citation Analysis]
78 Andoniadou CL. Pituitary Stem Cells During Normal Physiology and Disease. In: Pfaff D, Christen Y, editors. Stem Cells in Neuroendocrinology. Cham: Springer International Publishing; 2016. pp. 103-11. [DOI: 10.1007/978-3-319-41603-8_8] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
79 Asa SL, Mete O. Immunohistochemical Biomarkers in Pituitary Pathology. Endocr Pathol 2018;29:130-6. [DOI: 10.1007/s12022-018-9521-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
80 Mu W, Li S, Xu J, Guo X, Wu H, Chen Z, Qiao L, Helfer G, Lu F, Liu C, Wu QF. Hypothalamic Rax+ tanycytes contribute to tissue repair and tumorigenesis upon oncogene activation in mice. Nat Commun 2021;12:2288. [PMID: 33863883 DOI: 10.1038/s41467-021-22640-z] [Reference Citation Analysis]
81 Chen Y, Hu F, Wang J, Huang K, Liu W, Tan Y, Zhao K, Xiao Q, Lei T, Shu K. Clinical Features of Craniopharyngioma With Tumoral Hemorrhage: A Retrospective Case-Controlled Study. Front Surg 2022;9:845273. [DOI: 10.3389/fsurg.2022.845273] [Reference Citation Analysis]
82 Mao J, Qiu B, Mei F, Liu F, Feng Z, Fan J, Nie J, Huang L, Liao X, Wang Z, Zeng J, Weng Z, Zang N, Qi S, Bao Y. Interleukin-1α leads to growth hormone deficiency in adamantinomatous craniopharyngioma by targeting pericytes: implication in pituitary fibrosis. Metabolism 2019;101:153998. [PMID: 31666193 DOI: 10.1016/j.metabol.2019.153998] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
83 Zamora C, Castillo M. Sellar and Parasellar Imaging. Neurosurgery 2017;80:17-38. [DOI: 10.1093/neuros/nyw013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
84 Martinez-Barbera JP. Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma. Neuropathol Appl Neurobiol 2015;41:721-32. [PMID: 25611703 DOI: 10.1111/nan.12226] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
85 Zhang XY, Yuan K, Fang YL, Wang CL. Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report. World J Clin Cases 2022; 10(18): 6211-6217 [DOI: 10.12998/wjcc.v10.i18.6211] [Reference Citation Analysis]
86 Wang Y, Deng J, Wang L, Zhou T, Yang J, Tian Z, Yang J, Chen H, Tang X, Zhao S, Zhou L, Tong A, Xu J. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma. J Immunother Cancer 2020;8:e000406. [PMID: 32958683 DOI: 10.1136/jitc-2019-000406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
87 Fenstermaker R, Abad A. Imaging of Pituitary and Parasellar Disorders: . CONTINUUM: Lifelong Learning in Neurology 2016;22:1574-94. [DOI: 10.1212/con.0000000000000380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Baldo F, Marin M, Murru FM, Barbi E, Tornese G. Dealing With Brain MRI Findings in Pediatric Patients With Endocrinological Conditions: Less Is More? Front Endocrinol 2022;12:780763. [DOI: 10.3389/fendo.2021.780763] [Reference Citation Analysis]
89 Duan D, Wehbeh L, Mukherjee D, Hamrahian AH, Rodriguez FJ, Gujar S, Khalafallah AM, Hage C, Caturegli P, Gallia GL, Ahima RS, Maruthur NM, Salvatori R. Preoperative BMI Predicts Postoperative Weight Gain in Adult-onset Craniopharyngioma. J Clin Endocrinol Metab 2021;106:e1603-17. [PMID: 33417676 DOI: 10.1210/clinem/dgaa985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Lim EA, Alves CAPF, Picariello S, Aquilina K, Bisdas S, Loebel U, Mankad K, D'Arco F. Neuroimaging of paediatric pineal, sellar and suprasellar tumours: a guide to differential diagnosis. Childs Nerv Syst 2021. [PMID: 34529090 DOI: 10.1007/s00381-021-05359-6] [Reference Citation Analysis]
91 Hoffmann A, Adelmann S, Lohle K, Claviez A, Müller HL. Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis. Eur J Pediatr 2018;177:125-32. [DOI: 10.1007/s00431-017-3042-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
92 Pal R, Chatterjee D, Singla R, Jain N, Bhansali A, Dutta P. Co-Occurrence of Craniopharyngioma and IgG4-Related Hypophysitis: An Epiphenomenon or a Mere Coincidence? World Neurosurg 2020;136:193-7. [PMID: 31927125 DOI: 10.1016/j.wneu.2019.12.181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
93 Kalina MA, Wilczek M, Kalina-Faska B, Skała-Zamorowska E, Mandera M, Małecka Tendera E. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience. J Pediatr Endocrinol Metab 2015;28:45-51. [PMID: 25536662 DOI: 10.1515/jpem-2014-0425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
94 Santi D, Corona G. Primary and Secondary Hypogonadism. In: Simoni M, Huhtaniemi IT, editors. Endocrinology of the Testis and Male Reproduction. Cham: Springer International Publishing; 2017. pp. 687-747. [DOI: 10.1007/978-3-319-44441-3_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
95 Gomes DC, Jamra SA, Leal LF, Colli LM, Campanini ML, Oliveira RS, Martinelli CE, Elias PCL, Moreira AC, Machado HR, Saggioro F, Neder L, Castro M, Antonini SR. Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas. European Journal of Endocrinology 2015;172:603-8. [DOI: 10.1530/eje-14-0934] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 4.9] [Reference Citation Analysis]
96 Pascual JM, Prieto R, Rosdolsky M. Craniopharyngiomas primarily affecting the hypothalamus. Handb Clin Neurol 2021;181:75-115. [PMID: 34238481 DOI: 10.1016/B978-0-12-820683-6.00007-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Daubenbüchel AMM, Hoffmann A, Eveslage M, Özyurt J, Lohle K, Reichel J, Thiel CM, Martens H, Geenen V, Müller HL. Oxytocin in survivors of childhood-onset craniopharyngioma. Endocrine 2016;54:524-31. [DOI: 10.1007/s12020-016-1084-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
98 Shoemaker A, Proietto J, Abuzzahab MJ, Markovic T, Malloy J, Kim DD. A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity: SHOEMAKER et al. Diabetes Obes Metab 2017;19:1165-70. [DOI: 10.1111/dom.12928] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
99 Beck-peccoz P, Rodari G, Giavoli C, Lania A. Central hypothyroidism — a neglected thyroid disorder. Nat Rev Endocrinol 2017;13:588-98. [DOI: 10.1038/nrendo.2017.47] [Cited by in Crossref: 67] [Cited by in F6Publishing: 44] [Article Influence: 13.4] [Reference Citation Analysis]
100 Enriquez-Marulanda A, Sierra-Ruiz M, Pabón LM, Lobato-Polo J. Intracavitary Irradiation as a Safe Alternative for Cystic Craniopharyngiomas: Case Report and Review of the Literature. Case Rep Med 2016;2016:3601395. [PMID: 27366151 DOI: 10.1155/2016/3601395] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
101 van Santen HM, Schouten-Meeteren AY, Serlie M, Meijneke RW, van Trotsenburg AS, Verberne H, Holleman F, Fliers E. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity. J Pediatr Endocrinol Metab 2015;28:53-7. [PMID: 25514327 DOI: 10.1515/jpem-2014-0337] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
102 Müller HL. Risk-adapted treatment and follow-up management in childhood-onset craniopharyngioma. Expert Review of Neurotherapeutics 2016;16:535-48. [DOI: 10.1586/14737175.2016.1166959] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
103 Hoffmann A, Warmuth-Metz M, Lohle K, Reichel J, Daubenbüchel AM, Sterkenburg AS, Müller HL. Fusiform dilatation of the internal carotid artery in childhood-onset craniopharyngioma: multicenter study on incidence and long-term outcome. Pituitary 2016;19:422-8. [PMID: 27125511 DOI: 10.1007/s11102-016-0722-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 4.6] [Reference Citation Analysis]
104 Shi Q, Zhang J, Wang J, Du L, Shi Z, Xu M, Luo Y. Homologous Escherichia coli Identified in Cerebrospinal Fluid and Bloodstream. Front Cell Infect Microbiol 2021;11:674235. [PMID: 34568083 DOI: 10.3389/fcimb.2021.674235] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM. The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up. Eur J Endocrinol 2018;178:11-22. [PMID: 28882980 DOI: 10.1530/EJE-17-0387] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 3.6] [Reference Citation Analysis]
106 Delmadoros A. A case of undiagnosed craniopharyngioma. Clin Exp Optom 2022;:1-3. [PMID: 35157805 DOI: 10.1080/08164622.2021.2007034] [Reference Citation Analysis]
107 Madsen PJ, Buch VP, Douglas JE, Parasher AK, Lerner DK, Alexander E, Workman AD, Palmer JN, Lang S, Kennedy BC, Vossough A, Adappa ND, Storm PB. Endoscopic endonasal resection versus open surgery for pediatric craniopharyngioma: comparison of outcomes and complications. Journal of Neurosurgery: Pediatrics 2019;24:236-45. [DOI: 10.3171/2019.4.peds18612] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
108 Wolf P, Winhofer Y, Smajis S, Kruschitz R, Schindler K, Gessl A, Riedl M, Vila G, Raber W, Langer F, Prager G, Ludvik B, Luger A, Krebs M. Hormone Substitution after Gastric Bypass Surgery in Patients with Hypopituitarism Secondary to Craniopharyngioma. Endocrine Practice 2016;22:595-601. [DOI: 10.4158/ep15947.or] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
109 Otte A, Müller HL. Mini-review: Childhood-onset Craniopharyngioma. J Clin Endocrinol Metab 2021:dgab397. [PMID: 34086900 DOI: 10.1210/clinem/dgab397] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Daubenbüchel AM, Hoffmann A, Gebhardt U, Warmuth-Metz M, Sterkenburg AS, Müller HL. Hydrocephalus and hypothalamic involvement in pediatric patients with craniopharyngioma or cysts of Rathke's pouch: impact on long-term prognosis. Eur J Endocrinol 2015;172:561-9. [PMID: 25650403 DOI: 10.1530/EJE-14-1029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
111 Hoffmann A, Postma FP, Sterkenburg AS, Gebhardt U, Müller HL. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma. J Pediatr Endocrinol Metab 2015;28:35-43. [PMID: 25503864 DOI: 10.1515/jpem-2014-0415] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
112 Hölsken A, Buslei R. Models of human adamantinomatous craniopharyngioma tissue: Steps toward an effective adjuvant treatment. Brain Pathol 2017;27:358-63. [PMID: 28414888 DOI: 10.1111/bpa.12499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
113 Xia H, Zhang W. Luteal phase deficiency during the early trimester in a case with secondary hypopituitarism following craniopharyngioma resection. J Obstet Gynaecol Res 2021;47:3379-84. [PMID: 34219314 DOI: 10.1111/jog.14892] [Reference Citation Analysis]
114 Müller HL. Long-Term Management and Clinical Trials in Adamantinomatous Craniopharyngioma. In: Martinez-barbera JP, Lilian Andoniadou C, editors. Basic Research and Clinical Aspects of Adamantinomatous Craniopharyngioma. Cham: Springer International Publishing; 2017. pp. 179-214. [DOI: 10.1007/978-3-319-51890-9_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
115 Zieliński G, Sajjad EA, Robak Ł, Koziarski A. Subtemporal Approach for Gross Total Resection of Retrochiasmatic Craniopharyngiomas: Our Experience on 30 Cases. World Neurosurg 2018;109:e265-73. [PMID: 28987834 DOI: 10.1016/j.wneu.2017.09.159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
116 Eydoux R, Castinetti F, Authier M, Vialle M, Albarel F, Brue T, Courbiere B. Women's perceptions of femininity after craniopharyngioma: a qualitative study. Clin Endocrinol (Oxf) 2021;94:880-7. [PMID: 33296092 DOI: 10.1111/cen.14378] [Reference Citation Analysis]
117 Tian Z, Chen C, Zhang Y, Fan Y, Feng R, Xu J. Radiomic Analysis of Craniopharyngioma and Meningioma in the Sellar/Parasellar Area with MR Images Features and Texture Features: A Feasible Study. Contrast Media Mol Imaging 2020;2020:4837156. [PMID: 32158365 DOI: 10.1155/2020/4837156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
118 Haliloglu B, Atay Z, Guran T, Abalı S, Bas S, Turan S, Bereket A. Risk factors for mortality caused by hypothalamic obesity in children with hypothalamic tumours: Mortality in hypothalamic obesity. Pediatric Obesity 2016;11:383-8. [DOI: 10.1111/ijpo.12076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
119 Asha MJ, Oswari S, Takami H, Velasquez C, Almeida JP, Gentili F. Craniopharyngiomas: Challenges and Controversies. World Neurosurg 2020;142:593-600. [PMID: 32987615 DOI: 10.1016/j.wneu.2020.05.172] [Reference Citation Analysis]
120 Bailey S, Parkes J. Intracystic interferon therapy in childhood craniopharyngioma: who, when and how? Clin Endocrinol 2015;82:29-34. [DOI: 10.1111/cen.12568] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
121 Polovina TS, Kraljevic I, Solak M, Balasko A, Haxhiu A, Haxhiu A, Dusek T, Poljicanin T, Kastelan D. Early Basal Cortisol Level as a Predictor of Hypothalamic-Pituitary-Adrenal (HPA) Axis Function After Pituitary Tumor Surgery. Exp Clin Endocrinol Diabetes 2020;128:709-14. [PMID: 31091548 DOI: 10.1055/a-0885-1568] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Müller HL, Merchant TE, Puget S, Martinez-Barbera JP. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol 2017;13:299-312. [PMID: 28155902 DOI: 10.1038/nrendo.2016.217] [Cited by in Crossref: 80] [Cited by in F6Publishing: 57] [Article Influence: 16.0] [Reference Citation Analysis]
123 Burgess L, Chakraborty S, Malone S. Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy. Radiol Case Rep 2020;15:1750-5. [PMID: 32774574 DOI: 10.1016/j.radcr.2020.07.015] [Reference Citation Analysis]
124 Xie Z, Wang Q, Lu X. Endoscopic endonasal resection of nonfunctioning pituitary adenoma with radiological calcification. Pituitary 2019;22:381-6. [PMID: 31093846 DOI: 10.1007/s11102-019-00967-7] [Reference Citation Analysis]
125 Tan TSE, Patel L, Gopal-Kothandapani JS, Ehtisham S, Ikazoboh EC, Hayward R, Aquilina K, Skae M, Thorp N, Pizer B, Didi M, Mallucci C, Blair JC, Gaze MN, Kamaly-Asl I, Spoudeas H, Clayton PE. The neuroendocrine sequelae of paediatric craniopharyngioma: a 40-year meta-data analysis of 185 cases from three UK centres. Eur J Endocrinol 2017;176:359-69. [PMID: 28073908 DOI: 10.1530/EJE-16-0812] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 5.6] [Reference Citation Analysis]
126 Hsu EA, Miller JL, Perez FA, Roth CL. Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection. J Clin Endocrinol Metab 2018;103:370-5. [PMID: 29220529 DOI: 10.1210/jc.2017-02080] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
127 Heinks K, Boekhoff S, Hoffmann A, Warmuth-metz M, Eveslage M, Peng J, Calaminus G, Müller HL. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. Endocrine 2018;59:364-72. [DOI: 10.1007/s12020-017-1489-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
128 Vasilev V, Rostomyan L, Daly AF, Potorac I, Zacharieva S, Bonneville JF, Beckers A. MANAGEMENT OF ENDOCRINE DISEASE: Pituitary 'incidentaloma': neuroradiological assessment and differential diagnosis. Eur J Endocrinol 2016;175:R171-84. [PMID: 27068689 DOI: 10.1530/EJE-15-1272] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
129 Müller HL. Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome. Endocrine 2016;51:1-3. [DOI: 10.1007/s12020-015-0800-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
130 Boekhoff S, Bison B, Genzel D, Eveslage M, Otte A, Friedrich C, Flitsch J, Müller HL. Cerebral Infarction in Childhood-Onset Craniopharyngioma Patients: Results of KRANIOPHARYNGEOM 2007. Front Oncol 2021;11:698150. [PMID: 34336685 DOI: 10.3389/fonc.2021.698150] [Reference Citation Analysis]
131 Müller HL. Hypothalamic involvement in craniopharyngioma-Implications for surgical, radiooncological, and molecularly targeted treatment strategies. Pediatr Blood Cancer 2018;65:e26936. [DOI: 10.1002/pbc.26936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
132 Stache C, Bils C, Fahlbusch R, Flitsch J, Buchfelder M, Stefanits H, Czech T, Gaipl U, Frey B, Buslei R, Hölsken A. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin. Neurosurg Focus 2016;41:E14. [PMID: 27903123 DOI: 10.3171/2016.9.FOCUS16316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
133 Hölsken A, Schwarz M, Gillmann C, Pfister C, Uder M, Doerfler A, Buchfelder M, Schlaffer S, Fahlbusch R, Buslei R, Bäuerle T. Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology. PLoS One 2018;13:e0197895. [PMID: 29795641 DOI: 10.1371/journal.pone.0197895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
134 Thimsen V, John N, Buchfelder M, Flitsch J, Fahlbusch R, Stefanits H, Knosp E, Losa M, Buslei R, Hölsken A. Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue. Sci Rep 2017;7:15856. [PMID: 29158570 DOI: 10.1038/s41598-017-15977-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
135 Hasegawa H, Jentoft ME, Young WF Jr, Lakomkin N, Van Gompel JJ, Link MJ, Atkinson JL, Meyer FB. Collision of Craniopharyngioma and Pituitary Adenoma: Comprehensive Review of an Extremely Rare Sellar Condition. World Neurosurg 2021;149:e51-62. [PMID: 33647491 DOI: 10.1016/j.wneu.2021.02.091] [Reference Citation Analysis]
136 Romijn JA. The chronic syndromes after previous treatment of pituitary tumours. Nat Rev Endocrinol 2016;12:547-56. [DOI: 10.1038/nrendo.2016.84] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
137 Chen B, Chen C, Zhang Y, Huang Z, Wang H, Li R, Xu J. Differentiation between Germinoma and Craniopharyngioma Using Radiomics-Based Machine Learning. J Pers Med 2022;12:45. [PMID: 35055362 DOI: 10.3390/jpm12010045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
138 Wijnen M, van den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent MC, Dallenga AHG, van den Berge JH, van Rij CM, van der Lely AJ, Neggers SJCMM. Very long-term sequelae of craniopharyngioma. Eur J Endocrinol 2017;176:755-67. [PMID: 28325825 DOI: 10.1530/EJE-17-0044] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 7.4] [Reference Citation Analysis]
139 Zhang Y, Chen C, Tian Z, Xu J. Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features. Jpn J Radiol 2020;38:1125-34. [PMID: 32710133 DOI: 10.1007/s11604-020-01021-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
140 Coury JR, Davis BN, Koumas CP, Manzano GS, Dehdashti AR. Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review. Neurosurg Rev 2020;43:41-8. [DOI: 10.1007/s10143-018-0978-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
141 Drapeau A, Walz PC, Eide JG, Rugino AJ, Shaikhouni A, Mohyeldin A, Carrau RL, Prevedello DM. Pediatric craniopharyngioma. Childs Nerv Syst 2019;35:2133-45. [PMID: 31385085 DOI: 10.1007/s00381-019-04300-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
142 Hu C, Chen J, Meng Y, Zhang J, Wang Y, Liu R, Yu X. Phosphorus-32 interstitial radiotherapy for recurrent craniopharyngioma: Expressions of vascular endothelial growth factor and its receptor-2 and imaging features of tumors are associated with tumor radiosensitivity. Medicine (Baltimore) 2018;97:e11136. [PMID: 29952957 DOI: 10.1097/MD.0000000000011136] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Rangel-Castilla L, Russin JJ, Spetzler RF. Surgical management of skull base tumors. Rep Pract Oncol Radiother 2016;21:325-35. [PMID: 27330418 DOI: 10.1016/j.rpor.2014.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
144 Van Gerven L, Qian Z, Starovoyt A, Jorissen M, Meulemans J, van Loon J, De Vleeschouwer S, Lambert J, Bex M, Vander Poorten V. Endoscopic, Endonasal Transsphenoidal Surgery for Tumors of the Sellar and Suprasellar Region: A Monocentric Historical Cohort Study of 369 Patients. Front Oncol 2021;11:643550. [PMID: 34026618 DOI: 10.3389/fonc.2021.643550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
145 Aquilina K, Buchfelder M. Surgical Treatment of Human ACP. In: Martinez-barbera JP, Lilian Andoniadou C, editors. Basic Research and Clinical Aspects of Adamantinomatous Craniopharyngioma. Cham: Springer International Publishing; 2017. pp. 137-58. [DOI: 10.1007/978-3-319-51890-9_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
146 Müller HL. Craniopharyngioma: long-term consequences of a chronic disease. Expert Rev Neurother 2015;15:1241-4. [PMID: 26523617 DOI: 10.1586/14737175.2015.1100078] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
147 Chapman PR, Singhal A, Gaddamanugu S, Prattipati V. Neuroimaging of the Pituitary Gland: Practical Anatomy and Pathology. Radiol Clin North Am 2020;58:1115-33. [PMID: 33040852 DOI: 10.1016/j.rcl.2020.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
148 Martinez-Barbera JP, Buslei R. Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models. J Pediatr Endocrinol Metab 2015;28:7-17. [PMID: 25503464 DOI: 10.1515/jpem-2014-0442] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
149 Nemergut DR, Townsend AR. The importance of interdisciplinary communication with patients about complex, chronic illnesses: our experiences as parents of a child with a craniopharyngioma. J Pediatr Endocrinol Metab 2015;28:3-5. [PMID: 25514329 DOI: 10.1515/jpem-2014-0445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
150 Chen X, Tong Y, Shi Z, Chen H, Yang Z, Wang Y, Chen L, Yu J. Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach. BMC Neurol 2019;19:6. [PMID: 30616515 DOI: 10.1186/s12883-018-1216-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
151 Nussbaum PE, Nussbaum LA, Torok CM, Patel PD, Yesavage TA, Nussbaum ES. Case report and literature review of BRAF-V600 inhibitors for treatment of papillary craniopharyngiomas: A potential treatment paradigm shift. J Clin Pharm Ther 2022. [PMID: 35023192 DOI: 10.1111/jcpt.13600] [Reference Citation Analysis]
152 Haliloglu B, Bereket A. Hypothalamic obesity in children: pathophysiology to clinical management. J Pediatr Endocrinol Metab 2015;28:503-13. [PMID: 25781673 DOI: 10.1515/jpem-2014-0512] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
153 Roth CL. Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention. J Clin Med 2015;4:1774-97. [PMID: 26371051 DOI: 10.3390/jcm4091774] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
154 Jacob J, Feuvret L, Mazeron J, Simon J, Canova C, Riet F, Blais E, Jenny C, Maingon P. Radioterapia dei tumori cerebrali primitivi dell’adulto. EMC - Neurologia 2019;19:1-11. [DOI: 10.1016/s1634-7072(18)41587-5] [Reference Citation Analysis]
155 Foran SJ, Laperriere N, Edelstein K, Janzen L, Tadic T, Ramaswamy V, Shultz D, Gentili F, Bouffet E, Tsang DS. Reirradiation for recurrent craniopharyngioma. Adv Radiat Oncol 2020;5:1305-10. [PMID: 33305092 DOI: 10.1016/j.adro.2020.07.020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Marchesini N, Soda C, Ricci UM, Sedia M, Sala F, Pinna G. 12 Years delayed postoperative spinal recurrence of craniopharyngioma. Case report and literature review. Br J Neurosurg 2019;33:687-9. [PMID: 29199465 DOI: 10.1080/02688697.2017.1406454] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
157 Dissaux G, Josset S, Thillays F, Lucia F, Bourbonne V, Pradier O, Pasquier D, Biau J. Radiotherapy of benign intracranial tumours. Cancer Radiother 2021:S1278-3218(21)00194-3. [PMID: 34953692 DOI: 10.1016/j.canrad.2021.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Müller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 2016;23:81-9. [PMID: 26574645 DOI: 10.1097/MED.0000000000000214] [Cited by in Crossref: 70] [Cited by in F6Publishing: 19] [Article Influence: 11.7] [Reference Citation Analysis]
159 Mourad F, Cataldi F, Patuzzo A, Tunnera S, Dunning J, Fernández-de-Las-Peñas C, Maselli F. Craniopharyngioma in a young woman with symptoms presenting as mechanical neck pain associated with cervicogenic headache: a case report. Physiother Theory Pract 2021;37:549-58. [PMID: 31271335 DOI: 10.1080/09593985.2019.1636433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
160 Greuter L, Guzman R, Soleman J. Typical Pediatric Brain Tumors Occurring in Adults-Differences in Management and Outcome. Biomedicines 2021;9:356. [PMID: 33808415 DOI: 10.3390/biomedicines9040356] [Reference Citation Analysis]
161 Delannes M, Latorzeff I, Chand ME, Huchet A, Dupin C, Colin P. [Radiotherapy of benign intracranial tumors]. Cancer Radiother 2016;20 Suppl:S88-95. [PMID: 27523417 DOI: 10.1016/j.canrad.2016.07.029] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
162 Boekhoff S, Bogusz A, Sterkenburg AS, Eveslage M, Müller HL. Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo). European Journal of Endocrinology 2018;179:331-41. [DOI: 10.1530/eje-18-0505] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 3.8] [Reference Citation Analysis]
163 Wijnen M, Olsson DS, van den Heuvel-eibrink MM, Wallenius V, Janssen JAMJL, Delhanty PJD, van der Lely AJ, Johannsson G, Neggers SJCMM. Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case–control study with 2 years of follow-up. Int J Obes 2017;41:210-6. [DOI: 10.1038/ijo.2016.195] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
164 Kim JH, Kim H, Dan K, Kim SI, Park SH, Han D, Kim YH. In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas. Sci Rep 2021;11:21206. [PMID: 34707096 DOI: 10.1038/s41598-021-00483-4] [Reference Citation Analysis]
165 Bogusz A, Boekhoff S, Warmuth-Metz M, Calaminus G, Eveslage M, Müller HL. Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma. Endocr Connect 2019;8:481-92. [PMID: 30925462 DOI: 10.1530/EC-19-0074] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
166 Martinez-Barbera JP, Andoniadou CL. Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma. Stem Cells 2016;34:268-76. [PMID: 26763580 DOI: 10.1002/stem.2267] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
167 Mende KC, Kellner T, Petersenn S, Honegger J, Evangelista-Zamora R, Droste M, Stalla G, Deutschbein T, Wang Y, Moskopp D, Knappe U, Schilbach K, Flitsch J. Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma. J Clin Endocrinol Metab 2020;105:dgz043. [PMID: 31589293 DOI: 10.1210/clinem/dgz043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
168 Melmed S, Kleinberg D. Pituitary Masses and Tumors. Williams Textbook of Endocrinology. Elsevier; 2016. pp. 232-99. [DOI: 10.1016/b978-0-323-29738-7.00009-5] [Cited by in Crossref: 13] [Article Influence: 2.2] [Reference Citation Analysis]
169 Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM. Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study. Eur J Endocrinol 2018;178:93-102. [PMID: 29046325 DOI: 10.1530/EJE-17-0707] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
170 Mazerkina NA, Savateev AN, Gorelyshev SK, Mariashev SA, Beregovskaya SA, Konovalov AN. [Hepatopulmonary syndrome: a rare manifestation of cirrhosis in patient with diencephalic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma]. Probl Endokrinol (Mosk) 2021;67:58-66. [PMID: 34766492 DOI: 10.14341/probl12723] [Reference Citation Analysis]
171 Mende KC, Pantel TF, Flitsch J. Revived Attention for Adult Craniopharyngioma. Exp Clin Endocrinol Diabetes 2021;129:172-7. [PMID: 32750720 DOI: 10.1055/a-1217-7282] [Reference Citation Analysis]
172 Pascual JM, Prieto R, Carrasco R, Barrios L. Basal Recess in Third Ventricle Tumors: A Pathological Feature Defining a Clinical-Topographical Subpopulation of Papillary Craniopharyngiomas. J Neuropathol Exp Neurol 2022:nlac020. [PMID: 35472085 DOI: 10.1093/jnen/nlac020] [Reference Citation Analysis]
173 Elfers CT, Roth CL. Robust Reductions of Excess Weight and Hyperphagia by Beloranib in Rat Models of Genetic and Hypothalamic Obesity. Endocrinology 2017;158:41-55. [PMID: 27849360 DOI: 10.1210/en.2016-1665] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]